Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone.

by Eberechukwu Onukwugha, Young Kwok, Jay P Ciezki, Candice Yong, Catherine Plaisant, Chandana A Reddy, C Daniel Mullins, Brian Seal, Adriana Valderrama, Arif Hussain
Published 2017-01-01

177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer

by Clara Santos-Cuevas, Guillermina Ferro-Flores, Francisco O. García-Pérez, Nallely Jiménez-Mancilla, Gerardo Ramírez-Nava, Blanca Ocampo-García, Myrna Luna-Gutiérrez, Erika Azorín-Vega, Jenny Davanzo, Irma Soldevilla-Gallardo
Published 2018-01-01

Fournier gangrene with extensive necrosis of urethra and bladder mucosa: A rare occurrence in a patient with advanced prostate cancer

by Somorendro S Paonam, Sananda Bag
Published 2015-01-01

An unusual presentation of a patient with advanced prostate cancer, massive ascites and peritoneal metastasis: Case report and literature review

by Dimitrios Petrakis, George Pentheroudakis, Sevasti Kamina, Lambrini Pappa, Evangelos Papadiotis, Vassiliki Malamou-Mitsi, Nicholas Pavlidis
Published 2015-05-01

Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer

by Diletta Di Mitri, Michela Mirenda, Jelena Vasilevska, Arianna Calcinotto, Nicolas Delaleu, Ajinkya Revandkar, Veronica Gil, Gunther Boysen, Marco Losa, Simone Mosole, Emiliano Pasquini, Rocco D’Antuono, Michela Masetti, Elena Zagato, Giovanna Chiorino, Paola Ostano, Andrea Rinaldi, Letizia Gnetti, Mariona Graupera, Ana Raquel Martins Figueiredo Fonseca, Ricardo Pereira Mestre, David Waugh, Simon Barry, Johann De Bono, Andrea Alimonti
Published 2019-08-01

Predictive clinical indicators of biochemical progression in advanced prostate cancer patients receiving Leuplin depot as androgen deprivation therapy.

by Chien-Hua Chen, Ju-Ton Hsieh, Kuo-How Huang, Yeong-Shiau Pu, Hong-Chiang Chang
Published 2014-01-01

Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer

by Pedro Nazareth Aguiar Jr., Pui San Tan, Sarah Simko, Carmelia Maria Noia Barreto, Bárbara de Souza Gutierres, Auro del Giglio, Gilberto de Lima Lopes Jr

Prediction of organ-confined disease after robot-assisted radical prostatectomy in patients with clinically locally-advanced prostate cancer

by Ho Won Kang, Hae Do Jung, Joo Yong Lee, Jong Kyou Kwon, Seong Uk Jeh, Kang Su Cho, Won Sik Ham, Young Deuk Choi
Published 2019-01-01

Long-Term Efficacy and Tolerability of Abdominal Once-Yearly Histrelin Acetate Subcutaneous Implants in Patients with Advanced Prostate Cancer

by Sean Woolen, Cameron Holzmeyer, Emily Nesbitt, Paul F. Siami
Published 2014-01-01

Prostate Specific Antigen as a Prognostic Factor for Biochemical Progression of Advanced Prostate Cancer Patients Receiving Hormone Treatment

by Chien-Hua Chen, 陳建華
Published 2009

EIF4E Phosphorylation as a Mechanism of Resistance To mTOR and Androgen Receptor Inhibition in Advanced Prostate Cancer

by D'Abronzo, Leandro Salati
Published 2017

Review of the article “Metastatic testicular and epididymal lesions in a patient with advanced prostate cancer: a case report and literature review”

by V. I. Shirokorad
Published 2021-02-01

PHARMACODYNAMIC EQUIVALENCE OF USING 3-MONTH AND 28-DAY SUSTAINED-RELEASE DECAPEPTYL DEPOT FORMULATIONS IN PATIENTS WITH ADVANCED PROSTATE CANCER

by P. Teillac, C. F. Heyns, A. V. Kaisary, O. Bouchot, J. Blumberg
Published 2014-07-01

A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer

by Thierry Gil, Fouad Aoun, Patrick Cabri, Pascal Maisonobe, Roland van Velthoven
Published 2015-06-01

Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer

by Yu-Cheng Lu, Chao-Yuan Huang, Yu-Chuan Lu, Kuo-How Huang, Po-Ming Chow, Yi-Kai Chang, Fan-Ching Hung, Chung-Hsin Chen, Fu-Shan Jaw, Jian-Hua Hong
Published 2021-01-01

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000-2016. Nationwide, population-based study in Sweden

by A.W. Orrason, M. Westerberg, H. Garmo, I.F. Lissbrant, D. Robinson, P. Stattin
Published 2020-07-01

Comparing the characteristics of advanced Prostate Cancer (PC) patients with and without DNA Damage Repair mutations (DDRm): A systematic review

by E. Castro, S.H. Lang, S.L. Swift, R.M. Leadley, A. Chalker, C. Noake, K.M. Fox, R.G.W. Quek
Published 2020-11-01

Retzius-sparing robot-assisted laparoscopic radical prostatectomy: functional and early oncologic results in aggressive and locally advanced prostate cancer

by Joanne Nyaboe Nyarangi-Dix, Magdalena Görtz, Georgi Gradinarov, Luisa Hofer, Viktoria Schütz, Claudia Gasch, Jan Philipp Radtke, Markus Hohenfellner
Published 2019-11-01

Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT)

by Malcolm Brown, Marie Murphy, Lauri McDermott, Helen McAneney, Joe M. O’Sullivan, Suneil Jain, Gillian Prue
Published 2019-08-01